FDA Pursuing Regulatory Authority over E-Cigarettes
The electronic cigarette business is booming, with the industry experiencing a triple in sales this year, making them a $1.5 billion dollar business.
With the aid of television advertisements, Nascar sponsorships, and free giveaways, e-cigarettes are reaping the benefits of minimal to no regulation by the government. However, the continuation these marketing methods remain uncertain in light of the plausibility that the U.S. Food and Drug Administration (FDA) may opt to regulate the industry.
E-Cigarette Industry May Face FDA Regulation
According to Bloomberg, the FDA is scheduled this month to decide whether or not the e-cigarette business should be included in the regulative measures that oversee the $90 billion dollar tobacco industry. The current regulations include restrictions on production, flavorings, advertising, and web sales.
E-cigarettes are an alternative to regular cigarettes and differ in that they do not release tar. Rather, liquid nicotine is heated to create a vapor that the user inhales.
There has been a noticeable push from marketers to get the product attention from potential consumers, before the FDA steps in. There have been massive TV ad campaigns, promotional giveaways at night clubs, and Nascar sponsorships promoting the product.
E-Cigarette Threat to Children
The CDC released a report in early September raising concerns about nicotine addiction in children. It was found the U.S. middle and high school students using e-cigarettes doubled from 4.7% to 10% in just one year’s time.
Grounds for FDA Regulation of E-Cgarettes
A 2009 law currently allows for the FDA to influence the manufacturing, marketing, and industry practices of tobacco products. The law also extends the right to include other related products in the regulation.
The FDA has presented a proposal to the White House Office of Management and Budget, attempting to expand its regulative authority beyond cigarettes.
Contact an Experienced Product Liability Attorney
Thomas J. Henry are leaders in the area of product liability litigation. Our Defective Drug and Products Division has extensive knowledge and resources in order to represent our clients efficiently and aggressively. We represent a multitude of people who are battling against manufacturers of defective drugs and/or products.
Your choice does matter. If you or a loved one has suffered serious injuries because of a recalled product, call Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.
RECENT MEDICAL MALPRACTICE RESULT
$10.9 MillionExpenses: $175,000.00 | Attorneys Fees: $3,200,000.00 | Net to Client: $4,029,762.00 (Purchase of a Lifetime Annuity)
RECENT VEHICLE RECALL RESULT
$30.2 MillionExpenses: $39,576.15 | Attorneys Fees: $10,060,980.00 | Net to Client: $20,121,960.57